SaniMed Science Group partners with early-stage MedTech startups, providing investment, consulting, and financial support to accelerate growth. With expertise in regulatory processes and market strategy, SaniMed guides companies from concept to FDA approval and launch.

Funds

SSG MedTech Fund 2024

The SSG MedTech 2024 is an investment fund dedicated to advancing innovation in medical technology and healthcare. With a focus on early-stage, high-impact MedTech startups, the fund supports AI-driven diagnostics, biotech, and digital health solutions that improve patient outcomes and optimize healthcare systems. Leveraging a strategic network, including partnerships with Top Healthcare Institution as well as SaniMed’s MedTech expertise, the fund provides startups with essential resources, mentorship, and capital to foster transformative advancements in healthcare technology. Read More

Projects

PROJECTS

Name: SaniMed Science Group
Address: 7505 Fannin Street, Houston, TX, 77054, US
Telephone: 1-832-875-1816

INVESTMENT

TomoWave Medical Group

TomoWave Medical Group is dedicated to advancing and applying cutting-edge 3D/4D Photoacoustic Tomography (PAT) technology. This innovative technology enables structural, functional, and molecular imaging through its exceptional resolution, contrast, and sensitivity. It facilitates real-time, image-guided animal experiments and enables non-invasive, synchronous image-guided biopsies and surgeries. As a leader in the research, development, and production of photoacoustic tomography imaging equipment, TomoWave has successfully launched two pioneering product lines: the Preclinical Animal Photoacoustic Imaging System and the Clinical Photoacoustic Diagnostic System. Notably, the Preclinical Animal Photoacoustic Imaging System has achieved significant commercial success, with sales exceeding 3.5 million USD.